Managers / Q1 2025 · view latest →
EQUITEC PROPRIETARY MARKETS, LLC
CIK 0001143261 · 111 W. JACKSON, 20TH FL.OOR, CHICAGO, IL, 60604 · 312 692-5009
Summary
Equitec Proprietary Markets, LLC reported $141M in U.S.-listed holdings across 66 positions for Q1 2025.
Its largest position, USX1, represents 7.2% of the portfolio.
Compared with Q4 2024, the fund opened 10 new positions and exited 16.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 78.9% · $111M
- ETP · 19.9% · $28M
- MLP · 1.0% · $1M
- Other · 0.1% · $115,231
- Equity WRT · 0.1% · $96,276
- Other · 0.0% · $5,140
Quarter-over-Quarter Changes full breakdown →
vs Q4 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ITCIEURINTRA-CELLULAR THERAPIES INC | NEW | +199.1K | 199.1K | +$26M | $26M |
| WBAWALGREENS BOOTS ALLIANCE INC | NEW | +168.6K | 168.6K | +$2M | $2M |
| ABALLIANCEBERNSTEIN HLDG L P | NEW | +36.0K | 36.0K | +$1M | $1M |
| KBDCKAYNE ANDERSON BDC INC | NEW | +81.3K | 81.3K | +$1M | $1M |
| BLUEBIRD BIO INC | NEW | +262.5K | 262.5K | +$1M | $1M |
| ALTGALTA EQUIPMENT GROUP INC | NEW | +55.6K | 55.6K | +$260,905 | $260,905 |
| CHECKPOINT THERAPEUTICS INC | NEW | +27.8K | 27.8K | +$112,312 | $112,312 |
| CMRXEURCHIMERIX INC | NEW | +2.5K | 2.5K | +$21,275 | $21,275 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2025
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | USX1UNITED STATES STL CORP NEWhistory → | COM | 7.21% | $10M | 239.8K |
| 2 | SPDR S&P 500 ETF TR | TR UNIT | 5.97% | $8M | 15.0K |
| 3 | ITCIEURINTRA-CELLULAR THERAPIES INChistory → | COM | 5.17% | $7M | 55.1K |
| 4 | KELKELLANOVAhistory → | COM | 1.94% | $3M | 33.1K |
| 5 | AMEDAMEDISYS INChistory → | COM | 1.12% | $2M | 17.0K |
| 6 | KBDCKAYNE ANDERSON BDC INC | COM SHS | 0.94% | $1M | 81.3K |
| 7 | S9QSPIRIT AEROSYSTEMS HLDGS INC | COM CL A | 0.43% | $609,942 | 17.7K |
| 8 | BLUEBIRD BIO INC | COM NEW | 0.38% | $540,284 | 110.7K |
| 9 | WBAWALGREENS BOOTS ALLIANCE INC | COM | 0.29% | $402,120 | 36.0K |
| 10 | KLGWK KELLOGG CO | COM SHS | 0.29% | $401,590 | 20.1K |
| 11 | GMEGAMESTOP CORP NEW | CL A | 0.23% | $317,502 | 14.2K |
| 12 | CDZICADIZ INC | COM NEW | 0.23% | $316,575 | 108.0K |
| 13 | ALTGALTA EQUIPMENT GROUP INC | COMMON STOCK | 0.19% | $260,905 | 55.6K |
| 14 | BWBABCOCK & WILCOX ENTERPRISES | COM | 0.16% | $220,120 | 327.4K |
| 15 | PMCBPHARMACYTE BIOTECH INC | COM NEW | 0.07% | $103,409 | 82.7K |
| 16 | ISHARES TR | 20 YR TR BD ETF | 0.05% | $72,824 | 800 |
| 17 | BBAI/WSBIGBEAR AI HLDGS INC | *W EXP 12/08/202 | 0.05% | $69,700 | 85.0K |
| 18 | GOOGALPHABET INC | CAP STK CL C | 0.02% | $31,246 | 200 |
| 19 | D-WAVE QUANTUM INC | *W EXP 08/05/202 | 0.01% | $19,505 | 5.3K |
| 20 | ABALLIANCEBERNSTEIN HLDG L P | UNIT LTD PARTN | 0.01% | $19,155 | 500 |
| 21 | AWREAWARE INC MASS | COM | 0.01% | $11,060 | 7.0K |
| 22 | SIRISIRIUSXM HOLDINGS INC | COMMON STOCK | 0.01% | $10,822 | 480 |
| 23 | TMCTMC THE METALS COMPANY INC | COM | 0.00% | $6,880 | 4.0K |
| 24 | JDJD.COM INC | SPON ADS CL A | 0.00% | $5,140 | 125 |
| 25 | WEATUSDTEUCRIUM COMMODITY TR | WHEAT FD | 0.00% | $4,680 | 1.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $187M | 81 | May 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $174M | 84 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $440M | 77 | Nov 26, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $106M | 65 | Aug 6, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $141M | 66 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $102M | 72 | Jan 29, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $117M | 73 | Oct 18, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $79M | 80 | Jul 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $164M | 90 | Apr 26, 2024 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2023 | $135M | 109 | Jan 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $405M | 132 | Oct 17, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $331M | 106 | Jul 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $212M | 162 | Apr 28, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $315M | 213 | Jan 31, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $380M | 292 | Oct 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $353M | 300 | Jul 18, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $457M | 265 | Apr 22, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $739M | 441 | Jan 31, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $540M | 274 | Oct 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $334M | 304 | Jul 20, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $318M | 321 | Apr 19, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $384M | 128 | Jan 26, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $131M | 99 | Oct 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $257M | 58 | Jan 30, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.